Accelerate Diagnostics

Accelerate Diagnostics is an in vitro diagnostics company. The company's Accelerate Pheno? system utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial and fungal cells are resistant or susceptible to a particular antimicrobial. The Accelerate PhenoTest? BC Kit, which is the test kit for the system, provides ID and AST results for patients suspected of bacteremia or fungemia, both conditions with morbidity and mortality risk. The Accelerate Pheno? system comprises of a robotic pipettor for fluidic manipulation, an optical system, and an imaging system.
  • TickerAXDX
  • ISINUS00430H1023
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

Jonathan Moreland

InsiderInsights Daily Ratings Report: November 30, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland

InsiderInsights Daily Ratings Report: November 13, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland

Daily Insider Ratings Report: May 17, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

ValuEngine Rating and Forecast Report for AXDX

Vermilion Booster Shots: Attractive bottom-fishing stocks

ResearchPool Subscriptions

Get the most out of your insights

Get in touch